271 related articles for article (PubMed ID: 18720087)
41. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
42. Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy.
Lucioni C; D'Ambrosi A; Mazzi S; Pollesello P; Apajasalo M; Fedele F
Adv Ther; 2012 Dec; 29(12):1037-50. PubMed ID: 23233357
[TBL] [Abstract][Full Text] [Related]
43. [Inotropic agents in advanced and refractory heart failure].
Mangiavacchi M; Gronda E
Ital Heart J Suppl; 2003 Jan; 4(1):3-7. PubMed ID: 12690928
[No Abstract] [Full Text] [Related]
44. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.
Peacock WF; Hollander JE; Diercks DB; Lopatin M; Fonarow G; Emerman CL
Emerg Med J; 2008 Apr; 25(4):205-9. PubMed ID: 18356349
[TBL] [Abstract][Full Text] [Related]
45. Clinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: results from the Italian Survey on Acute Heart Failure.
Miani D; Fresco C; Lucci D; Albanese MC; Gonzini L; Fioretti PM; Maggioni AP; Tavazzi L;
Am Heart J; 2009 Jul; 158(1):126-32. PubMed ID: 19540402
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
[TBL] [Abstract][Full Text] [Related]
47. Rotating inotrope therapy in a pediatric population with decompensated heart failure.
Ryerson LM; Alexander PM; Butt WW; Shann FA; Penny DJ; Shekerdemian LS
Pediatr Crit Care Med; 2011 Jan; 12(1):57-60. PubMed ID: 20453705
[TBL] [Abstract][Full Text] [Related]
48. Levosimendan reversing low output syndrome after heart transplantation.
Petäjä LM; Sipponen JT; Hämmäinen PJ; Eriksson HI; Salmenperä MT; Suojaranta-Ylinen RT
Ann Thorac Surg; 2006 Oct; 82(4):1529-31. PubMed ID: 16996977
[TBL] [Abstract][Full Text] [Related]
49. How mechanical circulatory support helps not to need it--new strategies in pediatric heart failure.
Schweigmann U; Velik-Salchner C; Kilo J; Schermer E
Artif Organs; 2011 Nov; 35(11):1105-9. PubMed ID: 21954874
[TBL] [Abstract][Full Text] [Related]
50. [Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment].
Ambrosio G; Di Lenarda A; Fedele F; Gabrielli D; Metra M; Oliva F; Perna G; Senni M; De Maria R
G Ital Cardiol (Rome); 2009 Jul; 10(7):422-33. PubMed ID: 19761100
[TBL] [Abstract][Full Text] [Related]
51. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.
Elkayam U; Tasissa G; Binanay C; Stevenson LW; Gheorghiade M; Warnica JW; Young JB; Rayburn BK; Rogers JG; DeMarco T; Leier CV
Am Heart J; 2007 Jan; 153(1):98-104. PubMed ID: 17174645
[TBL] [Abstract][Full Text] [Related]
52. Association between inotrope treatment and 90-day mortality in patients with septic shock.
Wilkman E; Kaukonen KM; Pettilä V; Kuitunen A; Varpula M
Acta Anaesthesiol Scand; 2013 Apr; 57(4):431-42. PubMed ID: 23298252
[TBL] [Abstract][Full Text] [Related]
53. Timing of levosimendan in cardiac surgery.
Aksun M; Karahan N; Adanir T; Aran G; Yetkin U; Oztürk T; Sencan A; Ozgürbüz U; Gürbüz A
Anadolu Kardiyol Derg; 2009 Jun; 9(3):223-30. PubMed ID: 19520657
[TBL] [Abstract][Full Text] [Related]
54. Levosimendan: a new option in acute septic cardiac failure?
Powell BP; De Keulenaer B
Emerg Med Australas; 2007 Apr; 19(2):177; author reply 177-8. PubMed ID: 17448109
[No Abstract] [Full Text] [Related]
55. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
[TBL] [Abstract][Full Text] [Related]
56. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.
Allen LA; Fonarow GC; Grau-Sepulveda MV; Hernandez AF; Peterson PN; Partovian C; Li SX; Heidenreich PA; Bhatt DL; Peterson ED; Krumholz HM;
Circ Heart Fail; 2014 Mar; 7(2):251-60. PubMed ID: 24488983
[TBL] [Abstract][Full Text] [Related]
57. Experience with levosimendan in 32 paediatric patients.
Vilaboa Pedrosa C; Martínez Roca C; Yáñez Gómez P; Martín Herranz MI
Pediatr Cardiol; 2015 Jun; 36(5):1038-41. PubMed ID: 25608697
[TBL] [Abstract][Full Text] [Related]
58. Review of current and investigational pharmacologic agents for acute heart failure syndromes.
Shin DD; Brandimarte F; De Luca L; Sabbah HN; Fonarow GC; Filippatos G; Komajda M; Gheorghiade M
Am J Cardiol; 2007 Jan; 99(2A):4A-23A. PubMed ID: 17239703
[TBL] [Abstract][Full Text] [Related]
59. Levosimendan in heart failure after surgical repair of cardiac rupture.
Torrado H; Ventura JL; Ruiz-Majoral A; Farrero E; Rodriguez-Castro D; Carrio ML; Miralles A
Minerva Cardioangiol; 2009 Feb; 57(1):137-8. PubMed ID: 19202525
[No Abstract] [Full Text] [Related]
60. Intracoronary infusion of levosimendan to treat postpericardiotomy heart failure.
Caimmi PP; Grossini E; Molinari C; Vacca G; Teodori G
Ann Thorac Surg; 2006 Nov; 82(5):e33-4. PubMed ID: 17062205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
